Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Aberrant promoter methylation of HIN-1 gene may contribute to the pathogenesis of breast cancer: a meta-analysis.

Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine - 1 Aug 2014

Dai Di, Dong Xi-Hua, Cheng Shi-Tong, Zhu Ge, Guo Xiao-Lin

Abstract excerpt

We conducted the present meta-analysis of relevant cohort studies to evaluate whether promoter methylation of the high in normal-1 (HIN-1) gene contributes to breast cancer. The MEDLINE (1966 ~ 2013), Cochrane Library (Issue 12, 2013), EMBASE (1980 ~ 2013), CINAHL (1982 ~ 2013), Web of Science (1945 ~ 2013), and Chinese Biomedical (CBM) (1982 ~ 2013) databases were searched without any language restrictions....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Breast Neoplasms
Share to Cytokines

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to DNA Methylation

Share to Genetic Predisposition to Disease

Share to Promoter Regions, Genetic

Share to Tumor Suppressor Proteins

Source

Identifiers

PMID: 24850174
DOI: 10.1007/s13277-014-2055-1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Aberrant promoter methylation of HIN-1 gene may contribute to the pathogenesis of breast cancer: a meta-analysis.PMID 24850174Read ↗

Promoter methylation of HIN-1 in the progression to esophageal squamous cancer.Semantic proximity Read ↗

Aberrant promoter methylation of the CHD1 gene may contribute to the pathogenesis of breast cancer: a meta-analysis.Semantic proximity Read ↗

Lack of HIN-1 methylation in BRCA1-linked and "BRCA1-like" breast tumors.Semantic proximity Read ↗

Constitutional methylation of the BRCA1 promoter is specifically associated with BRCA1 mutation-associated pathology in early-onset breast cancer.Semantic proximity Read ↗

Association of BRCA1 Promoter Methylation with Breast Cancer in Asia: A Meta- AnalysisSemantic proximity Read ↗

Lack of HIN-1 methylation defines specific breast tumor subtypes including medullary carcinoma of the breast and BRCA1-linked tumors.Semantic proximity Read ↗

Epigenetic changes in BRCA1-mutated familial breast cancer.Semantic proximity Read ↗

DNA methylation patterns in breast cancer, paired benign tissue from ipsilateral and contralateral breast, and healthy controlsSemantic proximity Read ↗

Emerging Role of Epigenetic Modifiers in Breast Cancer Pathogenesis and Therapeutic ResponseSemantic proximity Read ↗

Alu and LINE-1 hypomethylation is associated with HER2 enriched subtype of breast cancer.Semantic proximity Read ↗

Promoter Methylation status of HIN-1 associated with outcomes of ovarian clear cell adenocarcinomaSemantic proximity Read ↗

FEN1 gene variants confer reduced risk of breast cancer in chinese women: A case-control study.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.